First Wave BioPharma Inc (FWBI)
2.74
+0.01
(+0.37%)
USD |
NASDAQ |
Apr 26, 16:00
2.82
+0.08
(+2.92%)
After-Hours: 20:00
First Wave BioPharma Price to Book Value: 1.540 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 26, 2024 | 1.540 |
April 25, 2024 | 1.534 |
April 24, 2024 | 1.698 |
April 23, 2024 | 1.754 |
April 22, 2024 | 1.636 |
April 19, 2024 | 1.462 |
April 18, 2024 | 1.596 |
April 17, 2024 | 1.630 |
April 16, 2024 | 1.698 |
April 15, 2024 | 1.838 |
April 12, 2024 | 1.866 |
April 11, 2024 | 1.922 |
April 10, 2024 | 1.922 |
April 09, 2024 | 2.052 |
April 08, 2024 | 2.125 |
April 05, 2024 | 2.226 |
April 04, 2024 | 2.299 |
April 03, 2024 | 2.237 |
April 02, 2024 | 2.293 |
April 01, 2024 | 2.383 |
March 28, 2024 | 2.462 |
March 27, 2024 | 2.220 |
March 26, 2024 | 2.176 |
March 25, 2024 | 2.258 |
March 22, 2024 | 2.422 |
Date | Value |
---|---|
March 21, 2024 | 2.455 |
March 20, 2024 | 2.538 |
March 19, 2024 | 2.658 |
March 18, 2024 | 2.669 |
March 15, 2024 | 2.598 |
March 14, 2024 | 2.943 |
March 13, 2024 | 3.579 |
March 12, 2024 | 2.464 |
March 11, 2024 | 2.546 |
March 08, 2024 | 2.958 |
March 07, 2024 | 3.106 |
March 06, 2024 | 3.232 |
March 05, 2024 | 3.388 |
March 04, 2024 | 3.049 |
March 01, 2024 | 4.008 |
February 29, 2024 | 3.418 |
February 28, 2024 | 3.293 |
February 27, 2024 | 2.990 |
February 26, 2024 | 2.574 |
February 23, 2024 | 2.539 |
February 22, 2024 | 2.210 |
February 21, 2024 | 2.149 |
February 20, 2024 | 2.240 |
February 16, 2024 | 2.266 |
February 15, 2024 | 2.231 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7082
Minimum
Dec 18 2023
22.40
Maximum
May 08 2019
4.902
Average
4.260
Median
Price to Book Value Benchmarks
BioVie Inc | 2.580 |
Jaguar Health Inc | 10.42 |
Benitec Biopharma Inc | 1.156 |
Immuneering Corp | 0.4813 |
NovaBay Pharmaceuticals Inc | 1.739 |
Price to Book Value Related Metrics
Price | 2.74 |
Earnings Yield | -11.11K% |
Market Cap | 5.549M |